Microbot Medical Inc. Files 8-K on Equity Sales
Ticker: MBOT · Form: 8-K · Filed: Aug 27, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $2.10, $2, $8.6 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, financials, sec-filing
TL;DR
Microbot Medical sold unregistered equity, check financials.
AI Summary
Microbot Medical Inc. filed an 8-K on August 27, 2025, reporting unregistered sales of equity securities and financial statements. The company, incorporated in Delaware, is involved in surgical and medical instruments and apparatus.
Why It Matters
This filing indicates potential dilution for existing shareholders due to unregistered equity sales and provides updated financial information.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can lead to dilution and signal potential financial distress or a need for capital.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- August 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What type of equity securities were sold unregistered?
The filing does not specify the type of equity securities sold unregistered, only that such sales occurred.
Were these sales part of a private placement or other exemption from registration?
The filing indicates 'Unregistered Sales of Equity Securities' but does not detail the specific exemption claimed.
What are the financial implications of these unregistered sales?
The filing includes 'Financial Statements and Exhibits' which would detail the financial impact, but the summary of the filing itself does not provide specific dollar amounts for the sales.
When was Microbot Medical Inc. incorporated?
Microbot Medical Inc. was incorporated in Delaware.
What is the primary business of Microbot Medical Inc.?
Microbot Medical Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.
Filing Stats: 607 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-08-27 16:30:50
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $2.10 — per share of the Series H Options were $2.10 and Series I Options were $2.13, genera
- $2 — ns were $2.10 and Series I Options were $2.13, generating aggregate gross proceeds
- $8.6 million — ent fees and expenses, of approximately $8.6 million. As of August 27, 2025, the Company had
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001641172-25-025709.txt ( ) — 200KB
- mbot-20250827.xsd (EX-101.SCH) — 3KB
- mbot-20250827_lab.xml (EX-101.LAB) — 33KB
- mbot-20250827_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: August 27, 2025